Literature DB >> 11992539

Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells.

Ying-Tang Huang1, Jiuan-Jiuan Hwang, Lung-Ta Lee, Charles Liebow, Ping-Ping H Lee, Ferng-Chun Ke, Tung-Bin Lo, Andrew V Schally, Ming-Ting Lee.   

Abstract

The purpose of this study was to investigate the effects of a potent LHRH agonist, [D-Trp(6)]LHRH on the basal and EGF-induced cell proliferation and the metastasis-associated properties in A431 human epidermoid carcinoma. [D-Trp(6)]LHRH time-dependently inhibited the basal and EGF-stimulated growth of A431 cancer cells. It is assumed that phosphorylation/dephosphorylation of cellular proteins is highly related to cell growth. This study demonstrates that [D-Trp(6)]LHRH decreased the basal and EGF-induced total cellular kinase activity, particularly the tyrosine phosphorylation of several cellular proteins including the EGFR. In contrast, [D-Trp(6)]LHRH did not cause detectable changes in basal and EGF-stimulated serine/threonine phosphorylation of A431 cellular proteins. The inhibitory effect of [D-Trp(6)]LHRH on A431 cell proliferation was associated with apoptosis as evidenced by the cell morphology and DNA integrity (ladder pattern), the expression of interleukin 1beta-converting enzyme (ICE) and activation of caspase. Furthermore, EGF could rescue the remaining attached A431 cells following [D-Trp(6)]LHRH treatment for 48 hr, which suggests that limited exposure to [D-Trp(6)]LHRH did not channel all cells to irreversible apoptotic process. We also determined the effects of [D-Trp(6)]LHRH on metastasis-associated properties in A431 cells. [D-Trp(6)]LHRH reduced both basal and EGF-stimulated secretion of MMP-9 and MMP-2. In addition, [D-Trp(6)]LHRH suppressed the basal and EGF-induced invasive activity of A431 cells based on an in vitro invasion assay. In conclusion, this study indicates that [D-Trp(6)]LHRH may act partly through activating tyrosine phosphatase activity to inhibit cell proliferation and the metastasis-associated properties of A431 cancer cells. Our work suggests that [D-Trp(6)]LHRH may be therapeutically useful in limiting the tumor growth and metastasis of some neoplasms. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992539     DOI: 10.1002/ijc.10373

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop.

Authors:  K E Hayes; E L Walk; A G Ammer; L C Kelley; K H Martin; S A Weed
Journal:  Oncogene       Date:  2012-11-12       Impact factor: 9.867

2.  Transducer of Cdc42-dependent actin assembly promotes epidermal growth factor-induced cell motility and invasiveness.

Authors:  Jinghui Hu; Alka Mukhopadhyay; Andrew W B Craig
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

3.  Involvement of matrix metalloproteinases on the inhibition of cells invasion and migration by emodin in human neuroblastoma SH-SY5Y cells.

Authors:  Hsu-Feng Lu; Kuang-Chi Lai; Shu-Chun Hsu; Hui-Ju Lin; Chao-Lin Kuo; Ching-Lung Liao; Jai-Sing Yang; Jing-Gung Chung
Journal:  Neurochem Res       Date:  2009-03-17       Impact factor: 3.996

4.  GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor.

Authors:  Madelaine Cho-Clark; Darwin O Larco; Nina N Semsarzadeh; Florencia Vasta; Shaila K Mani; T John Wu
Journal:  Mol Endocrinol       Date:  2013-01-01

5.  The effects of CD148 Q276P/R326Q polymorphisms in A431D epidermoid cancer cell proliferation and epidermal growth factor receptor signaling.

Authors:  Lilly He; Keiko Takahashi; Lejla Pasic; Chikage Narui; Philipp Ellinger; Manuel Grundmann; Takamune Takahashi
Journal:  Cancer Rep (Hoboken)       Date:  2021-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.